Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry

By sjmartinez • May 21, 2024

Larsen CP, Vincenti F, D Kou T, Shadur CA, Bresnahan B, Jordan SC, Woodle ES, Goes N, Vella J, Wojciechowski D, Polinsky MS, Gomez-Caminero A. Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry. Transplant Direct. 2024 May 17;10(6):e1644. doi: 10.1097/TXD.0000000000001644. PMID: 38769981; PMCID: PMC11104716.

Tags: Cedars Sinai DoM, Nephrology, Publications

Polyploid cancer cells reveal signatures of chemotherapy resistance

Schmidt MJ, Naghdloo A, Prabakar RK, Kamal M, Cadaneanu R, Garraway IP, Lewis M, Aparicio A, Zurita-Saavedra A, Corn P, Kuhn P, Pienta KJ, Amend[...]

Implications of Tricuspid Regurgitation Severity in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair

Shechter A, Taheri H, Nagasaka T, Gupta A, Kaewkes D, Patel V, Suruga K, Dhillon M, Koseki K, Koren O, Makar M, Skaf S, Patel[...]

Gastritis: Pathophysiology and Clinical Management

Fansiwala K, Lewis MS, Pisegna JR. Gastritis: Pathophysiology and Clinical Management. Am J Gastroenterol. 2024 Nov 21. doi: 10.14309/ajg.0000000000003216. Epub ahead of print. PMID: 39569875.